Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01493310 | Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer | completed | Phase 1 | 9 | University of ChicagoOTHER | 1 | Sep 12, 2018 | clinicaltrials |
| NCT02046421 | Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer | completed | Phase 1 | 31 | University of ChicagoOTHER | 1 | Sep 11, 2018 |
| clinicaltrials |
| NCT00741260 | Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer | completed | Phase 1 / Phase 2 | 105 | Puma Biotechnology, Inc.INDUSTRY | 11 | Sep 5, 2018 | clinicaltrials |
| NCT00371488 | GW572016 Combined With Trastuzumab For The Treatment Of Previously Trastuzumab-Treated Breast Cancer | completed | Phase 1 | 11 | GlaxoSmithKlineINDUSTRY | 1 | Aug 31, 2018 | clinicaltrials |
| NCT00462956 | GW572016 In Patients With Advanced Or Metastatic Breast Cancer | completed | Phase 1 | 59 | GlaxoSmithKlineINDUSTRY | 1 | Aug 31, 2018 | clinicaltrials |
| NCT01031446 | Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 55 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Aug 31, 2018 | clinicaltrials |
| NCT00759785 | A Study of Dalotuzumab (MK-0646) in Breast Cancer Patients (MK-0646-013) | completed | Phase 1 | 48 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 15, 2018 | clinicaltrials |
| NCT00706030 | Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 92 | Puma Biotechnology, Inc.INDUSTRY | 11 | Aug 9, 2018 | clinicaltrials |
| NCT00268918 | Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients | completed | Phase 1 | 24 | Dana-Farber Cancer InstituteOTHER | 1 | Jul 27, 2018 | clinicaltrials |
| NCT01730612 | ImmunoTEP au 68-Ga- IMP-288 for Patients With a Recurrence of HER2 Negative Breast Carcinoma Expressing CEA(iTEPsein) | completed | Phase 1 / Phase 2 | 23 | Nantes University HospitalOTHER | 1 | Jul 27, 2018 | clinicaltrials |
| NCT00445458 | A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast Cancer | completed | Phase 1 / Phase 2 | 110 | Puma Biotechnology, Inc.INDUSTRY | 9 | Jul 26, 2018 | clinicaltrials |
| NCT00398567 | A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer | completed | Phase 1 / Phase 2 | 45 | Puma Biotechnology, Inc.INDUSTRY | 4 | Jul 24, 2018 | clinicaltrials |
| NCT01344031 | MK2206 in Combination With Anastrozole, Fulvestrant, or Anastrozole and Fulvestrant in Treating Postmenopausal Women With Metastatic Breast Cancer | completed | Phase 1 | 31 | National Cancer Institute (NCI)NIH | 1 | Jul 23, 2018 | clinicaltrials |
| NCT01484015 | Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia | completed | Phase 1 | 70 | Wake Forest University Health SciencesOTHER | 1 | Jul 18, 2018 | clinicaltrials |
| NCT01937689 | Study of Pyrotinib in Patients With Human Epidermalgrowth Factor Receptor 2 (HER2) Positive Advanced Breast Cancer | completed | Phase 1 | 40 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jul 9, 2018 | clinicaltrials |
| NCT02361112 | Study Evaluating Pyrotinib in Combination With Capecitabine In Patients With HER2 Positive Metastatic Breast Cancer(BLTN-Ic) | completed | Phase 1 | 38 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jul 9, 2018 | clinicaltrials |
| NCT00079625 | Stem Cell Transplant With Th2/Tc2 Cells to Treat Advanced Breast Cancer | completed | Phase 1 | 22 | National Cancer Institute (NCI)NIH | 1 | Jul 5, 2018 | clinicaltrials |
| NCT01246102 | AT13387 in Adults With Refractory Solid Tumors | completed | Phase 1 | 31 | National Cancer Institute (NCI)NIH | 1 | Jul 5, 2018 | clinicaltrials |
| NCT01994369 | Intraoperative Imagery of Breast Cancer With Folate-FITC (EC17) | completed | Phase 1 | 10 | University of PennsylvaniaOTHER | 1 | Jul 3, 2018 | clinicaltrials |
| NCT00892736 | Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy | completed | Phase 1 | 98 | National Cancer Institute (NCI)NIH | 1 | Jun 29, 2018 | clinicaltrials |
| NCT02060253 | Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer | completed | Phase 1 | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 14, 2018 | clinicaltrials |
| NCT00699491 | Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Jun 13, 2018 | clinicaltrials |
| NCT02738970 | A Dose-Finding Study of Pertuzumab (Perjeta) in Combination With Trastuzumab (Herceptin) in Healthy Male Participants and Women With Early Breast Cancer (EBC) | completed | Phase 1 | 88 | Hoffmann-La RocheINDUSTRY | 1 | Jun 12, 2018 | clinicaltrials |
| NCT00325598 | Partial Breast Irradiation (PBI) for Selected Patients With Early Breast Cancer | completed | Phase 1 / Phase 2 | 100 | Washington University School of MedicineOTHER | 1 | Jun 6, 2018 | clinicaltrials |
| NCT02270372 | Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast Cancer | completed | Phase 1 | 22 | Cascadian Therapeutics Inc.INDUSTRY | 1 | May 17, 2018 | clinicaltrials |
| NCT00080665 | Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast Cancer | completed | Phase 1 | 12 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Apr 24, 2018 | clinicaltrials |
| NCT03502395 | Serum Opiorphin Level After Intraoperative Intravenous Lidocaine Infusion | completed | Phase 1 | 80 | Assiut UniversityOTHER | 1 | Apr 19, 2018 | clinicaltrials |
| NCT00834678 | Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer | completed | Phase 1 / Phase 2 | 11 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 17, 2018 | clinicaltrials |
| NCT01042535 | Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 44 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Apr 11, 2018 | clinicaltrials |
| NCT01624441 | Dinaciclib and Epirubicin Hydrochloride in Treating Patients With Metastatic Triple-Negative Breast Cancer | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Mar 30, 2018 | clinicaltrials |
| NCT01520389 | Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment | completed | Phase 1 | 112 | Merrimack PharmaceuticalsINDUSTRY | 1 | Mar 21, 2018 | clinicaltrials |
| NCT03065010 | Study of BCD-115 in Women With ER(+) HER2(-) Local Advanced and Metastatic Breast Cancer | completed | Phase 1 | 6 | BiocadINDUSTRY | 1 | Mar 13, 2018 | clinicaltrials |
| NCT01750320 | Koning Breast Computed Tomography Guided Biopsy | completed | Phase 1 | 4 | Koning CorporationINDUSTRY | 1 | Mar 7, 2018 | clinicaltrials |
| NCT00707707 | Phase I/II Study of AZD2281 Given in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer | completed | Phase 1 | 19 | AstraZenecaINDUSTRY | 4 | Mar 6, 2018 | clinicaltrials |
| NCT00790816 | Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents | completed | Phase 1 | 500 | Novartis PharmaceuticalsINDUSTRY | 5 | Feb 28, 2018 | clinicaltrials |
| NCT01843725 | Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cancers(MOMENTUM1) | completed | Phase 1 | 37 | Jules Bordet InstituteOTHER | 1 | Jan 31, 2018 | clinicaltrials |
| NCT01367626 | Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fed Conditions | completed | Phase 1 | 28 | Roxane LaboratoriesINDUSTRY | 1 | Jan 23, 2018 | clinicaltrials |
| NCT01367652 | Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fasted Conditions | completed | Phase 1 | 28 | Roxane LaboratoriesINDUSTRY | 1 | Jan 23, 2018 | clinicaltrials |
| NCT02882581 | Metformin in Breast Cancer, Visualized With Positron Emission Tomography | completed | Phase 1 | 7 | Aarhus University HospitalOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT02014337 | Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors | completed | Phase 1 | 37 | Corcept TherapeuticsINDUSTRY | 1 | Jan 17, 2018 | clinicaltrials |
| NCT01145430 | Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer | completed | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 1 | Dec 22, 2017 | clinicaltrials |
| NCT01605630 | Family Cancer Literacy to Promote Mammography Screening Among Navajo Women | completed | Phase 1 | 40 | Mayo ClinicOTHER | 1 | Dec 19, 2017 | clinicaltrials |
| NCT03376503 | Nanogen Pegfilgrastim (Pegcyte) PK/PD Clinical Study in Breast Cancer Patients | completed | Phase 1 | 24 | Nanogen Pharmaceutical Biotechnology Joint Stock CompanyINDUSTRY | 1 | Dec 19, 2017 | clinicaltrials |
| NCT01477489 | Veliparib With Radiation Therapy in Patients With Inflammatory or Loco-regionally Recurrent Breast Cancer | completed | Phase 1 | 33 | University of Michigan Rogel Cancer CenterOTHER | 1 | Dec 15, 2017 | clinicaltrials |
| NCT00998036 | Study of Temsirolimus, Erlotinib and Cisplatin in Solid Tumors | completed | Phase 1 | 9 | Columbia UniversityOTHER | 1 | Dec 13, 2017 | clinicaltrials |
| NCT00148902 | Effects Of GW572016 In Combination With Docetaxel (TAXOTERE) | completed | Phase 1 | 52 | GlaxoSmithKlineINDUSTRY | 1 | Dec 6, 2017 | clinicaltrials |
| NCT00258050 | To Examine The Effects Of Lapatinib On Orally And Intravenously Administered Midazolam In Cancer Patients | completed | Phase 1 | 24 | GlaxoSmithKlineINDUSTRY | 1 | Dec 6, 2017 | clinicaltrials |
| NCT01009437 | Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer | completed | Phase 1 | 28 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 5, 2017 | clinicaltrials |
| NCT00622674 | Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 37 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 2, 2017 | clinicaltrials |
| NCT00005023 | Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer | completed | Phase 1 | — | University of WashingtonOTHER | 1 | Nov 30, 2017 | clinicaltrials |
Data updated 24 days agoSource updated Sep 12, 2018source: clinicaltrials